Noninvasive Marker, Fibrospect II, Overestimates Fibrosis in Hepatitis C-Infected Patients with Chronic Renal Insufficiency
نویسندگان
چکیده
Mathews Journal of Gastroenterology & Hepatology Noninvasive Marker, Fibrospect II, Overestimates Fibrosis in Hepatitis C-Infected Patients with Chronic Renal Insufficiency Jonah N Rubin1, Noura M Sharabash2, Dingcai Cao3, Mary S Hammes4, Helen S Te5 1Department of Internal Medicine, University of Chicago Medicine, Section of Hospital Medicine, Chicago. 2Digestive Health Institute, Carle Foundation Hospital, Urbana. 3Department of Ophthalmology and Visual Sciences, University of Illinois Eye and Ear Infirmary, University of Illinois at Chicago College of Medicine, Chicago. 4Department of Internal Medicine, University of Chicago Medicine, Section of Nephrology, Chicago. 5Department of Internal Medicine, University of Chicago Medicine, Section of Gastroenterology, Hepatology and Nutrition, Chicago. Corresponding Author: Helen S Te, Department of Internal Medicine, University of Chicago Medicine, Section of Gastroenterology, Hepatology and Nutrition, Chicago, Tel: (773) 834 1288; Email: [email protected]
منابع مشابه
Overestimate of Fibrosis by FIBROSpect® II in African Americans Complicates the Management of their Chronic Hepatitis C.
BACKGROUND Evaluation of advanced fibrosis in patients with hepatitis C virus (HCV) infection is used to facilitate decisions on treatment strategy and to initiate additional screening measures. Unfortunately, most studies have predominately Caucasian (Cau) patients and may not be as relevant for African Americans (AA). AIMS This study specifically addresses the issue of defining minimal vs. ...
متن کاملClinical Effectiveness of Three Noninvasive Methods for Detecting Hepatic Fibrosis
Target audience includes clinicians and scientists who are interested in noninvasive technologies for the assessment of hepatic fibrosis. Introduction: Chronic liver disease and cirrhosis remain a leading cause of mortality in the United States, with 143,000 hospitalizations, 11,000 inhospital deaths and 6.7 billion dollars of total hospital charges in 2009 [1]. Currently, liver biopsy is the r...
متن کاملبررسی عوامل مرتبط با شدت فیبروز کبد در بیماران مبتلا به هپاتیتهای مزمن B و C
Background & Aim: Viral hepatitis has existed since the creation of human. The estimated prevalence of hepatitis is about 3-5%. For patients with chronic hepatitis C and moderate to severe liver fibrosis, antiviral therapy is strongly suggested, while the cases without fibrosis or with mild liver fibrosis are often followed up without receiving antiviral therapy. The purpose of the present s...
متن کاملSAFETY AND EFFICACY OF INTERFERON ALFA FOR THE TREATMENT OF CHRONIC HEPATITIS C INFECTED SUBJECTS WITH TRANSFUSION DEPENDENT THALASSEMIA IN IRAN
Up to 30% of Iranian adult multi-transfused thalassemic patients are infected with hepatitis C virus (HCV) which can intensify the progression of liver disease caused by iron overload in this group of patients. Our aim was to assess the biochemical and virological response of interferon alfa (INF-α) and its safety in thalassemic patients with chronic HCV infection. This trial was a single c...
متن کاملبررسی تأثیر عفونت هپاتیت ویروسی B و C بر بقای کلیه پیوندی در بیماران دریافتکننده کلیه
Background and Aim: Chronic liver disease and its complications are major problems in renal transplant recipients. Hepatitis B and C virus infections are currently the main causes of chronic liver disease in this group, and these may affect allograft outcome. Whether hepatitis B and C virus infections after renal transplantation adversely affect graft and patient survival, remains controver...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2017